No Data
No Data
Disc Medicine Is Maintained at Buy by Stifel
Disc Medicine Price Target Raised to $94.00/Share From $90.00 by Stifel
Stifel Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $94
Stifel Nicolaus Keeps Their Buy Rating on Disc Medicine (IRON)
Disc Medicine Prices Upsized $225.5 Million Offering
Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
far008 : $Vast Renewables (VSTE.US)$ has no short shares. we should see an uptick
103822628 : Sorry , unusual volume ticks means wat?
Stock_Drift OP 103822628 : Look at the volume. It’s unusual